HALO

Halozyme Therapeutics
HALO

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$7.22B
EV
$8.16B
Shares Outstanding
126.55M
Beta
1.32

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$68.13
P/E 2025E
11.68x
P/Revenue 2025E
6.06x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Halozyme Therapeutics, Inc.

gainify
HALO

Halozyme Therapeutics, Inc.

HALO

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company’s products are based on the patented reco...

Sector

Healthcare

Industry

Biotechnology

CEO

Torley, Helen

Employees

350

IPO Date

2004-03-16

Headquarters

12390 El Camino Real, San Diego, California, 92130, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved